Jinyu Bio-technology Co., Ltd. (SHA:600201)
17.60
+0.31 (1.79%)
Jan 22, 2026, 3:00 PM CST
Jinyu Bio-technology Revenue
Jinyu Bio-technology had revenue of 422.84M CNY in the quarter ending September 30, 2025, with 17.76% growth. This brings the company's revenue in the last twelve months to 1.33B, down -1.70% year-over-year. In the year 2024, Jinyu Bio-technology had annual revenue of 1.26B, down -21.45%.
Revenue (ttm)
1.33B
Revenue Growth
-1.70%
P/S Ratio
14.49
Revenue / Employee
762.68K
Employees
1,740
Market Cap
19.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.26B | -342.77M | -21.45% |
| Dec 31, 2023 | 1.60B | 69.56M | 4.55% |
| Dec 31, 2022 | 1.53B | -247.65M | -13.94% |
| Dec 31, 2021 | 1.78B | 194.41M | 12.29% |
| Dec 31, 2020 | 1.58B | 455.12M | 40.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 26.83B |
| Yili Chuanning Biotechnology | 4.74B |
| Anhui Anke Biotechnology (Group) | 2.58B |
| Tibet Cheezheng Tibetan Medicine | 2.39B |
| Pacific Shuanglin Bio-pharmacy | 2.38B |
| Sinocelltech Group | 1.89B |
| Inner Mongolia Furui Medical Science | 1.47B |
| BrightGene Bio-Medical Technology | 1.18B |